You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 101 to 125 of about 5880
Next 25
05/21/2024
Brain Tumor Awareness Month Webinar Series
05/20/2024
Brain Tumor Awareness Month Webinar Today
05/16/2024
Brain Tumor Awareness Month Webinar Tonight
05/13/2024
Musella Foundation Celebrates 26th Anniversary!
05/12/2024
TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II trial
05/06/2024
CIRM Awards $11.8 Million Grant for Clinical Trial in High-Grade Glioma Including Glioblastoma Using DB107, a Novel DGM7 Genetic Biomarker-Guided Gene Therapy
Minnesota Brain Tumor 5k Announces 15th Annul Fun Walk/Run
05/02/2024
04/29/2024
Path forward for glioblastoma treatment
New York Advocacy Alert!
04/28/2024
Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma
FDA approves new drug for pediatric low-grade glioma with BRAF fusions or mutation
04/22/2024
Carthera partners with Agenus and Northwestern University for phase 2a trial combining SonoCloud-9 with checkpoint inhibitors to treat glioblastoma
Urgent funding needed for DIPG sonodynamic therapy trial
Gene Therapy Is Halting Cancer - Can It Work Against Brain Tumors?
ROSALIE Trial of EO2401/Nivolumab/Bevacizumab in Recurrent Glioblastoma Concludes
04/15/2024
Ivy Brain Tumor Center Announces Promising Results of Phase 0/1 Glioblastoma Study at AACR Annual Meeting
Upcoming Musella Foundation May Webinars!
UCLA Brain Tumor Center to Host 24th Annual UCLA Brain Tumor Conference
`The Brain Surgeon`s Take` podcast episode with Dr. Al Musella on the Promising Pathway Act
04/11/2024
Evaluation of the EMulate Therapeutics Voyager`s ultra-low radiofrequency energy in murine model of glioblastoma
04/08/2024
Real-world cost-effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China
04/05/2024
Sex differences in adverse events in Medicare individuals > 66 years of age post glioblastoma treatment